90
Participants
Start Date
October 16, 2017
Primary Completion Date
February 12, 2018
Study Completion Date
February 12, 2018
AVC-H2
A total of 2.5g AVC-H2 daily (2 tablets in the morning and 2 in the evening)
Placebo
A total of 2.5g placebo daily (2 tablets in the morning and 2 in the evening)
Avicenna Nutraceutical, Atlanta
Lead Sponsor
Collaborators (1)
BioScreen Testing Services
UNKNOWN
Avicenna Nutraceutical
OTHER